The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.842
Bid: 0.842
Ask: 0.852
Change: 0.002 (0.24%)
Spread: 0.01 (1.188%)
Open: 0.84
High: 0.842
Low: 0.84
Prev. Close: 0.84
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

15 Feb 2018 16:30

RNS Number : 0526F
BioPharma Credit PLC
15 February 2018
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

BioPharma Credit Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

No

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

No

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

No

An event changing the breakdown of voting rights

No

Other (please specify):

Placing of Shares

Yes

3. Full name of person(s) subject to thenotification obligation:

Invesco Limited

4. Full name of shareholder(s) (if different from 3.):

 

5. Date of the transaction and date onwhich the threshold is crossed orreached:

30 March 2017

6. Date on which issuer notified:

31 March 2017

7. Threshold(s) that is/are crossed orreached:

5%,10%,11%,12%,13%,14%,15%,16%,17%,18%,19%

      
 

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary Shares

N/A

N/A

 

 

150,000,000

 

19.69%

GB00BDGKMY29

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

150,000,0000

19.69%

                 
 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

Invesco Asset Management Limited - 150,000,000

 

 

Proxy Voting:

10. Name of the proxy holder:

Invesco Limited

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

 

13. Additional information:

 

14. Contact name:

Philippa Holmes

15. Contact telephone number:

01491 417 447

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUVRNRWUAUAAR
Date   Source Headline
8th Feb 20247:00 amRNSDividend Declaration
7th Feb 20246:15 pmRNSTransaction in Own Shares
6th Feb 20246:15 pmRNSTransaction in Own Shares
6th Feb 20247:00 amRNSSTATEMENT RE COHERUS BIOSCIENCES, INC.
1st Feb 202410:39 amRNSTotal Voting Rights
31st Jan 20244:00 pmRNSNet Asset Value(s) and Monthly Factsheet
30th Jan 20246:15 pmRNSTransaction in Own Shares
29th Jan 20246:15 pmRNSTransaction in Own Shares
26th Jan 20246:15 pmRNSTransaction in Own Shares
25th Jan 20246:15 pmRNSTransaction in Own Shares
24th Jan 20246:15 pmRNSTransaction in Own Shares
23rd Jan 20246:15 pmRNSTransaction in Own Shares
22nd Jan 20246:15 pmRNSTransaction in Own Shares
22nd Jan 202412:35 pmRNSDirector/PDMR Shareholding
19th Jan 20246:15 pmRNSTransaction in Own Shares
18th Jan 20246:15 pmRNSTransaction in Own Shares
17th Jan 20246:15 pmRNSTransaction in Own Shares
16th Jan 20246:15 pmRNSTransaction in Own Shares
15th Jan 20246:15 pmRNSTransaction in Own Shares
12th Jan 20246:15 pmRNSTransaction in Own Shares
11th Jan 20246:15 pmRNSTransaction in Own Shares
10th Jan 20246:15 pmRNSTransaction in Own Shares
10th Jan 202410:36 amRNSTransaction in Own Shares
8th Jan 20246:15 pmRNSTransaction in Own Shares
5th Jan 20246:15 pmRNSTransaction in Own Shares
3rd Jan 20246:15 pmRNSTransaction in Own Shares
2nd Jan 20246:15 pmRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSUPDATE ON INVESTMENT
28th Dec 202311:04 amRNSResult of General Meeting
21st Dec 20234:00 pmRNSNet Asset Value(s) and Monthly Factsheet
11th Dec 202311:25 amRNSUPDATE ON INVESTMENT
7th Dec 20236:04 pmRNSPUBLICATION OF CIRCULAR AND NOTICE OF GM
1st Dec 20237:00 amRNSSTATEMENT RE IMMUNOGEN, INC.
29th Nov 20237:00 amRNSDIVIDEND DECLARATION
22nd Nov 20237:01 amRNSUPDATE ON INVESTMENT
22nd Nov 20237:00 amRNSNET ASSET VALUE(S)
2nd Nov 20237:00 amRNSUPDATE ON INVESTMENT
1st Nov 20237:00 amRNSUPDATE ON INVESTMENT
1st Nov 20237:00 amRNSTRIGGER OF A CONTINUATION RESOLUTION
31st Oct 20233:30 pmRNSDirector Declaration
24th Oct 20237:00 amRNSUPDATE ON INVESTMENT
20th Oct 20234:00 pmRNSNet Asset Value(s) and Monthly Factsheet
12th Oct 20237:00 amRNSUPDATE ON INVESTMENT
2nd Oct 20231:32 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSHalf-year Report
26th Sep 202311:20 amRNSUPDATE ON INVESTMENT
22nd Sep 20234:00 pmRNSNet Asset Value(s) and Monthly Factsheet
19th Sep 20237:00 amRNSUpdate on Investment
31st Aug 20237:00 amRNSNotice of Half Year Results
29th Aug 202311:25 amRNSUpdate on Investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.